ReviewNuclear medicine and molecular imaging2024
Imaging Procedure and Clinical Studies of [
Review in Nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Brain Serotonin Transporter Is Elevated in Obesity: Bayesian and Frequentist Meta-Analyses.Diabetes, obesity & metabolism · 2026Pooled it
- Equivocal Dopamine Transporter Imaging: Integrating Visual Assessment, Quantification, and Clinical Follow-Up.Life (Basel, Switzerland) · 2026Review
- Feasibility Study of Deep Learning-Driven Image Restoration for Fast, Low-Count [Diagnostics (Basel, Switzerland) · 2026Article
- Dopaminergic Radiopharmaceutical Imaging in Parkinsonian Syndromes: From Molecular Targets to Clinical Decision-Making.Pharmaceuticals (Basel, Switzerland) · 2026Review
- First-in-Human Imaging Results of PHAROS: A Versatile High-Resolution TOF/DOI PET Scanner for Brain, Breast, and Extremity Imaging.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026Article
- Altered Raphe-Centered Monoamine Transporter Covariance in Early Parkinson's Disease with Depressive Symptoms.Diagnostics (Basel, Switzerland) · 2026Article
- Hemiparkinsonism Associated With Possible Moyamoya Vasculopathy: The Role of Early Perfusion Imaging Using ¹⁸F-FP-CIT PET.Journal of clinical neurology (Seoul, Korea) · 2026Article
- Differentiating Early Alzheimer's Disease from MCI Using Comprehensive Semiquantitative Parameters in Dual-Phase Amyloid PET: A Pilot Study.Medicina (Kaunas, Lithuania) · 2026Article
- Quantitative analysis of striatal subregional asymmetry onAnnals of nuclear medicine · 2026Article
- An interactive cascaded deep learning framework with expert refinement for accurate striatal subregion segmentation.Scientific reports · 2026Article
- Identification of a robust multitarget protein panel for Parkinson's disease via absolute quantification and large-scale external replication.Brain communications · 2026Article
- Towards a Biologically Defined Diagnosis: Incorporating Pathophysiological Measures Into Parkinson's Disease Clinical Criteria.Parkinson's disease · 2026Review
- Development of AI-based dopamine transporter (DAT) image generation technique using early phase [18F]-FP-CIT PET imaging.PloS one · 2026Article
- Does Q.Clear Processing Change PET Ratios? Quantitative Evidence Using BTXBrain-DAT.Brain sciences · 2025Article
- Combining Dopamine Transporter and Amyloid PET Tracer: A Preclinical Study on Dual-Target Imaging.Molecular imaging and biology · 2025Article
- A Narrative Review on Biochemical Markers and Emerging Treatments in Prodromal Synucleinopathies.Clinics and practice · 2025Review
- Are the Nuclear Neuro-Imaging Biomarkers Reliable?Nuclear medicine and molecular imaging · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
N-3-[
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.